(XT) Exponential Technologies - Overview
Etf: Software, Semiconductors, Robotics, Cloud, Genomics
Dividends
| Dividend Yield | 8.04% |
| Yield on Cost 5y | 4.32% |
| Yield CAGR 5y | 77.92% |
| Payout Consistency | 85.7% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 17.2% |
| Relative Tail Risk | 5.64% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.94 |
| Alpha | 9.43 |
| Character TTM | |
|---|---|
| Beta | 0.989 |
| Beta Downside | 0.984 |
| Drawdowns 3y | |
|---|---|
| Max DD | 22.09% |
| CAGR/Max DD | 0.60 |
Description: XT Exponential Technologies January 12, 2026
The iShares Exponential Technologies ETF (NASDAQ: XT) aims to track a specialized subset of the Morningstar Global Markets Index, allocating at least 80 % of its assets to the index’s component securities or to securities that closely replicate their economic characteristics.
Key identifiers: Ticker XT; ETF structure; domiciled in the United States; classified under the “Miscellaneous Sector” category.
As of the latest filing, XT carries an expense ratio of 0.47 % and manages roughly $1.2 billion in assets. Its top holdings are heavily weighted toward firms leading in artificial intelligence, robotics, genomics, and clean-energy technologies, sectors that are being propelled by accelerating corporate R&D spend and robust global GDP growth forecasts.
For deeper quantitative insights, you might explore the fund’s profile on ValueRay.
What is the price of XT shares?
Over the past week, the price has changed by -3.10%, over one month by +0.54%, over three months by +3.75% and over the past year by +23.67%.
Is XT a buy, sell or hold?
What are the forecasts/targets for the XT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 81.2 | 14.1% |
XT Fundamental Data Overview February 02, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 3.72b USD (3.72b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 3.72b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 3.72b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.56% (E(3.72b)/V(3.72b) * Re(9.56%) + (debt-free company))
Discount Rate = 9.56% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)